Therapeutic Innovation Australia is a national consortium of translational research infrastructure. 
Through TIA, Australian researchers from the public and private sector can access a range of expertise and services to assist in the development of new therapeutic products.
The TIA Consortium includes national and international expertise in the development of small molecule pharmaceuticals, biologics & vaccines and cell & gene therapies.

6 July 2021

 

 

 

TIA announces the outcomes of Pipeline Accelerator 2020-21 (Round 2)

 

TIA is pleased to announce the outcomes of Pipeline Accelerator 2020-21 (Round 2). TIA is investing $620,000 in 18 ground-breaking therapeutic development projects.  

TIA-Logo_Dark-Blue_TRANS.png